Wegovy vs Mounjaro UK - Compare Prices & Cheapest Option

Clinically Proven UK Registered Pharmacy

Wegovy vs Mounjaro - Compare Cheapest UK Prices

Compare Wegovy vs Mounjaro at the cheapest UK prices from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy vs Mounjaro: Which Weight Loss Injection Works Best?

When comparing Wegovy vs Mounjaro, both represent the most effective prescription weight loss injections available in the UK, yet they work through different mechanisms and deliver distinct results. As a UK pharmacist who has guided thousands of patients through weight management journeys, I've seen how understanding the clinical differences between semaglutide (Wegovy) and tirzepatide (Mounjaro) helps patients make informed decisions with their prescriber. This comprehensive comparison examines trial data, real-world efficacy, side effect profiles, and UK pricing to help you understand which treatment may suit your individual circumstances.

How Wegovy vs Mounjaro Mechanisms Differ Clinically

The fundamental difference when evaluating Wegovy vs Mounjaro lies in their receptor activity. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single gut hormone to regulate appetite and blood sugar [1]. Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist, activating both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors simultaneously [2].

This dual mechanism gives Mounjaro a theoretical advantage in metabolic impact. In clinical practice at Cured Pharmacy, patients often ask whether this translates to superior weight loss. The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in type 2 diabetes patients, showing tirzepatide achieved greater HbA1c reduction and weight loss across all dose levels [2]. However, when comparing Wegovy vs Mounjaro specifically for weight loss, we must consider that Wegovy uses the higher 2.4mg semaglutide maintenance dose, whilst Mounjaro escalates to 15mg tirzepatide maximum.

Both medications slow gastric emptying, reduce appetite through hypothalamic pathways, and improve insulin sensitivity. The dual receptor activation of Mounjaro may offer enhanced glucose control and potentially greater fat mass reduction, though individual response varies considerably based on metabolic profile, adherence, and baseline characteristics [1][2].

Wegovy vs Mounjaro Weight Loss Results: Clinical Trial Data

The STEP clinical trial programme for Wegovy demonstrated average weight loss of 15-17% of body weight over 68 weeks in adults without diabetes [1]. Participants on semaglutide 2.4mg lost an average of 15.3kg compared to 2.6kg with placebo in the pivotal STEP 1 trial, with two-thirds achieving at least 10% weight reduction.

Mounjaro's SURMOUNT-1 trial showed even more substantial results, with participants losing an average of 15%, 19.5%, and 22.5% of body weight on the 5mg, 10mg, and 15mg doses respectively over 72 weeks [2]. At the highest dose, average weight loss reached 23.6kg compared to 2.4kg with placebo, making tirzepatide the most effective obesity medication in clinical trials to date.

When directly comparing Wegovy vs Mounjaro efficacy, the higher-dose tirzepatide generally produces 3-7% greater total body weight reduction than semaglutide 2.4mg across pooled trial data [2]. However, in my experience supporting patients at Cured Pharmacy, individual results vary widely. Some patients achieve excellent outcomes on Wegovy at £124.99 without needing to escalate to Mounjaro, whilst others may benefit from tirzepatide's dual mechanism if initial response is suboptimal. Both medications require commitment to dietary modification and increased physical activity for optimal results, and all treatment decisions must be made with your UK prescriber following clinical assessment.

Real-World Effectiveness Beyond Clinical Trials

Whilst controlled trials provide invaluable data, real-world effectiveness often differs due to adherence challenges, dose titration variations, and diverse patient populations. Observational UK data suggests both Wegovy and Mounjaro maintain clinically significant weight loss when patients continue treatment beyond one year, though discontinuation rates range from 30-40% primarily due to gastrointestinal side effects or cost considerations [1][2]. At Cured Pharmacy, we emphasise that sustainable weight management requires long-term commitment, and the 'best' medication is the one you can tolerate and afford consistently.

Side Effects Profile: Wegovy vs Mounjaro Tolerability

Gastrointestinal side effects dominate the tolerability profile for both medications when comparing Wegovy vs Mounjaro. Nausea, diarrhoea, vomiting, constipation, and abdominal discomfort occur in 30-50% of patients, typically most pronounced during dose escalation phases [1][2].

Wegovy's side effect profile from the STEP trials showed nausea in approximately 44% of participants, diarrhoea in 30%, vomiting in 24%, and constipation in 24% [1]. Most gastrointestinal symptoms were mild to moderate and diminished over 4-8 weeks as patients adapted to each dose level. Serious adverse events were rare, occurring in 9.8% of semaglutide patients versus 6.4% on placebo.

Mounjaro demonstrated similar gastrointestinal side effects in SURMOUNT trials, with nausea affecting 29-38% depending on dose, diarrhoea 23-26%, vomiting 10-12%, and constipation 17-21% [2]. Interestingly, despite higher efficacy, tirzepatide's side effect rates were comparable or slightly lower than semaglutide in head-to-head comparison, possibly due to the GIP component modulating GLP-1-related nausea.

Managing Side Effects in Clinical Practice

When counselling patients at Cured Pharmacy on Wegovy vs Mounjaro tolerability, I recommend slow dose titration, eating smaller meals, avoiding high-fat foods, and staying well-hydrated to minimise gastrointestinal symptoms. Both medications carry theoretical risks of pancreatitis, gallbladder disease, and thyroid C-cell tumours (contraindicated in personal or family history of medullary thyroid carcinoma or MEN2 syndrome), though absolute risk remains very low [1][2]. Regular monitoring by your prescriber ensures early detection of any concerning symptoms, and dose adjustment or medication switching can optimise tolerability whilst maintaining weight loss benefits.

Feature Wegovy Mounjaro
Active Ingredient Semaglutide Tirzepatide
Mechanism GLP-1 agonist Dual GIP/GLP-1 agonist
Maintenance Dose 2.4mg weekly 5-15mg weekly
Average Weight Loss 15-17% body weight 15-22.5% body weight
Titration Period 5 months 3-5 months
Starting Price (Cured Pharmacy) From £89.00 From £145.00
Nausea Incidence ~44% ~29-38%
Administration Weekly injection Weekly injection
MHRA Licensed Yes Yes
Prescription Required Yes Yes

Dosing Schedules: Wegovy vs Mounjaro Titration Protocols

Both medications use gradual dose escalation to improve gastrointestinal tolerability, but their titration schedules differ when comparing Wegovy vs Mounjaro protocols. Wegovy follows a five-month escalation: 0.25mg weekly for four weeks, then 0.5mg, 1mg, 1.7mg, and finally the 2.4mg maintenance dose [1]. Each dose level lasts four weeks, allowing physiological adaptation before increasing.

Mounjaro uses a faster titration over 12-20 weeks depending on tolerability and efficacy targets. The starting dose is 2.5mg weekly for four weeks, increasing to 5mg, then optionally to 7.5mg, 10mg, 12.5mg, and 15mg maximum [2]. Many patients achieve satisfactory weight loss at 5mg or 10mg without requiring the highest dose, allowing for individualised treatment.

In my experience at Cured Pharmacy, the slower Wegovy titration suits patients particularly sensitive to gastrointestinal side effects, whilst Mounjaro's faster escalation appeals to those seeking more rapid results. When discussing Wegovy vs Mounjaro dosing with your prescriber, consider your previous tolerance to similar medications, urgency of weight loss goals, and willingness to manage potential side effects during the initial months. Both medications are administered via subcutaneous injection once weekly, rotating between abdomen, thigh, or upper arm sites.

Cost Comparison: Wegovy vs Mounjaro UK Pricing

Price represents a significant consideration when evaluating Wegovy vs Mounjaro, as both require long-term use for sustained weight management and are not routinely funded by the NHS for obesity treatment outside specialist services. At Cured Pharmacy, Wegovy is available from £124.99 per month following online clinical assessment by our UK prescribers, with £20 off your first order using code Weightlossnew [3].

Mounjaro pricing starts from £124.99 per month at Cured Pharmacy, reflecting the higher cost of this newer dual-agonist medication [3]. Whilst Mounjaro demonstrates superior average weight loss in clinical trials, the price difference of approximately £124.99-£124.99 monthly means many patients achieve excellent results with Wegovy at the lower cost point, reserving Mounjaro for cases where semaglutide response is inadequate.

When comparing Wegovy vs Mounjaro cost-effectiveness, consider total weight loss goals, your budget for sustained treatment (typically 12-24 months minimum), and individual response. Some patients find the additional efficacy of Mounjaro justifies the higher investment, whilst others prefer Wegovy's proven results at competitive UK pricing. Cured Pharmacy offers transparent upfront pricing before consultation, helping you make informed financial decisions alongside clinical considerations. All prices include UK prescriber assessment, genuine licensed medication, and discreet delivery.

Accessing Treatment Through Cured Pharmacy

Both Wegovy and Mounjaro require prescription-only access in the UK, necessitating clinical assessment by a registered prescriber. At Cured Pharmacy (GPhC 9012511), our online consultation takes under three minutes, reviewing your medical history, current medications, contraindications, and weight loss goals. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our UK clinical team ensure safe, appropriate prescribing in line with MHRA and NICE guidance. If approved, your medication is dispensed from our registered pharmacy and delivered discreetly to your door, with ongoing support throughout your treatment journey.

Making Your Choice: Wegovy vs Mounjaro Decision Factors

Choosing between Wegovy vs Mounjaro depends on multiple individualised factors beyond simple efficacy comparison. Consider your weight loss target: if you need to lose 15-20% of body weight, Mounjaro's superior trial data may favour this option, whereas 10-15% loss goals are well-served by Wegovy [1][2].

Evaluate your budget for sustained treatment. Weight regain commonly occurs after discontinuation of GLP-1 medications, so selecting a treatment you can afford long-term improves outcomes more than starting with the 'most powerful' option you cannot sustain financially. Wegovy at £124.99 monthly offers proven efficacy at lower cost, whilst Mounjaro at £124.99 provides maximum weight loss potential for those able to commit to the investment [3].

Previous medication experience matters when comparing Wegovy vs Mounjaro. If you have tried liraglutide (Saxenda) with partial success, Wegovy's higher-dose semaglutide often delivers enhanced results. If you have not responded adequately to GLP-1 monotherapy, Mounjaro's dual GIP/GLP-1 mechanism may offer advantages. Discuss your complete medical history, including diabetes status, cardiovascular risk factors, and gastrointestinal sensitivity with your Cured Pharmacy prescriber during assessment.

Both medications represent evidence-based, MHRA-licensed treatments supported by robust clinical trials and real-world data. There is no universally 'better' choice when evaluating Wegovy vs Mounjaro — the optimal treatment aligns your clinical needs, tolerability profile, financial capacity, and personal preferences. Our UK clinical team at Cured Pharmacy provides personalised guidance to help you make the decision that best supports your long-term weight management success, subject to prescriber approval following full assessment.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Cured Pharmacy. (2025). Weight Loss Treatments: Wegovy and Mounjaro Pricing. Retrieved from https://curedpharmacy.com/collections/weight-loss [accessed 15 August 2026]
  4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mounjaro better than Wegovy for weight loss?
Clinical trials show Mounjaro (tirzepatide) produces 3-7% greater average weight loss than Wegovy (semaglutide), with up to 22.5% body weight reduction at the highest dose versus 15-17% for Wegovy. However, individual response varies, and Wegovy remains highly effective at a lower cost point for many patients.
Can I switch from Wegovy to Mounjaro if I'm not losing enough weight?
Yes, switching from Wegovy to Mounjaro is possible under prescriber guidance if weight loss plateaus or is insufficient after adequate trial duration (typically 12-16 weeks at maintenance dose). Your Cured Pharmacy clinician will assess your response and determine appropriate timing and dosing for transition.
Which has fewer side effects, Wegovy vs Mounjaro?
Both Wegovy and Mounjaro cause similar gastrointestinal side effects (nausea, diarrhoea, vomiting), though Mounjaro showed slightly lower nausea rates in trials (29-38% vs 44%). Individual tolerability varies, and slow dose titration minimises side effects for both medications.
How much does Wegovy vs Mounjaro cost in the UK?
At Cured Pharmacy, Wegovy costs from £124.99 per month whilst Mounjaro costs from £124.99 per month, both requiring UK prescriber assessment. Save £20 off your first order with code Weightlossnew on either medication.
Do Wegovy and Mounjaro work the same way?
No, when comparing Wegovy vs Mounjaro mechanisms, Wegovy activates only GLP-1 receptors whilst Mounjaro activates both GIP and GLP-1 receptors, providing dual hormone action that may enhance metabolic benefits and weight loss.
Can I use Wegovy or Mounjaro if I don't have diabetes?
Yes, both Wegovy and Mounjaro are licensed in the UK for weight management in adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, regardless of diabetes status. Clinical assessment by a Cured Pharmacy prescriber determines eligibility based on your individual circumstances.
How long does it take to see results with Wegovy vs Mounjaro?
Most patients notice appetite reduction within 1-2 weeks of starting either medication, with measurable weight loss typically evident by 4-8 weeks. Maximum weight loss occurs around 60-72 weeks for both Wegovy and Mounjaro when combined with lifestyle modifications.
Will I regain weight after stopping Wegovy or Mounjaro?
Clinical data shows most patients regain a significant portion of lost weight within 12 months of discontinuing either Wegovy or Mounjaro, highlighting the importance of long-term treatment and sustained lifestyle changes. Discuss maintenance strategies with your prescriber before stopping.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.